Researchers examined the links between peripheral spondyloarthritis and Crohn disease, and how the gut microbiome can influence risk of the painful condition.
A recent placebo-controlled clinical trial tested the efficacy and safety of filgotinib in the treatment of patients with moderate to severe Crohn disease.
A recent retrospective cohort study suggests a potential long-term link between COVID-19 and increased risk for autoimmune conditions, underscoring the importance of follow-up care for those previously...
